Literature DB >> 22122702

Epigenetic signatures in stem cells and cancer stem cells.

Hector Hernandez-Vargas1, Nino Sincic, Maria Ouzounova, Zdenko Herceg.   

Abstract

The physiological properties of pluripotency in stem cells and the processes of cell specialization are governed by epigenetic mechanisms, as they are inheritable but not dependent on the cell genotype. There is cumulating evidence demonstrating the presence of cells with stem cell properties within tumors, suggesting that these cells are responsible for tumor growth and heterogeneity. As epigenetic control of self-renewal and pluripotency is a hallmark of stem cells, there is increased interest in studying similar epigenetic mechanisms governing these stemness properties in cancer stem cells. Here we will review the evidence supporting a role for epigenetic mechanisms in the induction of cancer stem cells, with an emphasis on the epigenetic regulatory networks involved in the establishment of normal self-renewal and pluripotency, and their potential deregulation in cancer. We will also discuss the data supporting the plasticity of these mechanisms and its potential therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 22122702     DOI: 10.2217/epi.09.19

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  11 in total

Review 1.  New insights into the earliest stages of colorectal tumorigenesis.

Authors:  Chelsie K Sievers; William M Grady; Richard B Halberg; Perry J Pickhardt
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2017-05-26       Impact factor: 3.869

Review 2.  AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.

Authors:  Bowen Yan; David Claxton; Suming Huang; Yi Qiu
Journal:  Exp Hematol       Date:  2020-06-20       Impact factor: 3.084

3.  From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms.

Authors:  Marion Martin; Zdenko Herceg
Journal:  Genome Med       Date:  2012-01-31       Impact factor: 11.117

Review 4.  Metabostemness: a new cancer hallmark.

Authors:  Javier A Menendez; Tomás Alarcón
Journal:  Front Oncol       Date:  2014-09-29       Impact factor: 6.244

5.  Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.

Authors:  Carmen Oi-Ning Leung; Wing-Nga Mak; Alan Ka-Lun Kai; Kwan-Shuen Chan; Terence Kin-Wah Lee; Irene Oi-Lin Ng; Regina Cheuk-Lam Lo
Journal:  Oncotarget       Date:  2016-05-17

6.  Influence of hyperthermal regimes on experimental teratoma development in vitro.

Authors:  Ana Katusic Bojanac; Srdjan Rogosic; Nino Sincic; Gordana Juric-Lekic; Maja Vlahovic; Ljiljana Serman; Davor Jezek; Floriana Bulic-Jakus
Journal:  Int J Exp Pathol       Date:  2018-08-01       Impact factor: 1.925

7.  A Free Radical Scavenger Ameliorates Teratogenic Activity of a DNA Hypomethylating Hematological Therapeutic.

Authors:  Nikola Sobočan; Ana Katušić Bojanac; Nino Sinčić; Marta Himelreich-Perić; Jure Krasić; Željka Majić; Gordana Jurić-Lekić; Ljiljana Šerman; Maja Vlahović; Davor Ježek; Floriana Bulić-Jakuš
Journal:  Stem Cells Dev       Date:  2019-03-11       Impact factor: 3.272

8.  Epigenetic Inheritance From Normal Origin Cells Can Determine the Aggressive Biology of Tumor-Initiating Cells and Tumor Heterogeneity.

Authors:  Jiliang Feng; Dawei Zhao; Fudong Lv; Zhongyu Yuan
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

Review 9.  Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.

Authors:  Saeedeh Keyvani-Ghamsari; Khatereh Khorsandi; Azhar Rasul; Muhammad Khatir Zaman
Journal:  Clin Epigenetics       Date:  2021-05-29       Impact factor: 6.551

10.  Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133.

Authors:  Stella Chai; Man Tong; Kai Yu Ng; Pak Shing Kwan; Yuen Piu Chan; Tsun Ming Fung; Terence K Lee; Nathalie Wong; Dan Xie; Yun-Fei Yuan; Xin-Yuan Guan; Stephanie Ma
Journal:  Oncotarget       Date:  2014-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.